To test this hypothesis, we evaluated whether SK1 proteolysis is downstream of caspase‐2 activation using a variety of methods in WT p53 human breast cancer cells and also whether caspase‐2 is required for SK1 proteolysis using both biochemical and genetic models. Here, TP53 is linked to breast carcinoma.